Shandong Sino-Agri United Biotechnology Co.,Ltd (SHE:003042)
China · Delayed Price · Currency is CNY 18.40
+0.29 (1.60%)
At close: Feb 6, 2026
SHE:003042 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,993 | 2,011 | 1,673 | 1,931 | 1,617 | 1,565 |
Other Revenue | 2.59 | 2.59 | 7.81 | 2.04 | 8.2 | 3.44 |
| 1,995 | 2,014 | 1,681 | 1,933 | 1,625 | 1,568 | |
Revenue Growth (YoY) | 7.68% | 19.79% | -13.06% | 18.98% | 3.63% | 14.74% |
Cost of Revenue | 1,830 | 1,854 | 1,599 | 1,572 | 1,264 | 1,187 |
Gross Profit | 164.96 | 159.99 | 81.95 | 361.73 | 361.29 | 381.52 |
Selling, General & Admin | 165.38 | 176.37 | 192.63 | 159.9 | 151.37 | 156.24 |
Research & Development | 82.36 | 85.7 | 98.48 | 103.91 | 73.63 | 64.81 |
Other Operating Expenses | 17.08 | 10.46 | 8.98 | 9.15 | 7.14 | 5.5 |
Operating Expenses | 266.71 | 273.68 | 300.85 | 274.84 | 234.01 | 226.98 |
Operating Income | -101.74 | -113.69 | -218.9 | 86.89 | 127.28 | 154.53 |
Interest Expense | -37.54 | -40.19 | -32.19 | -25.44 | -22.78 | -23.6 |
Interest & Investment Income | 3.74 | 5.36 | 5.34 | 6.3 | 5.05 | 0.77 |
Currency Exchange Gain (Loss) | 10.93 | 10.93 | 7.34 | 4.5 | -1.23 | -12.14 |
Other Non Operating Income (Expenses) | -5.24 | -4.85 | -4.16 | -3.37 | -2.76 | -1.59 |
EBT Excluding Unusual Items | -129.85 | -142.43 | -242.58 | 68.88 | 105.56 | 117.98 |
Gain (Loss) on Sale of Investments | - | -0.01 | -2.05 | -2.19 | - | - |
Gain (Loss) on Sale of Assets | -0.94 | -0.72 | -0.09 | 0.63 | -1.77 | -1.83 |
Asset Writedown | -1.85 | - | - | -0.5 | -0.3 | - |
Other Unusual Items | 9.52 | 6.96 | 8.12 | 4.21 | 5.41 | 2.7 |
Pretax Income | -123.13 | -136.2 | -236.6 | 71.03 | 108.9 | 118.84 |
Income Tax Expense | -11.91 | -13.75 | -44.12 | -2.1 | 10.31 | 15.32 |
Net Income | -111.22 | -122.45 | -192.47 | 73.14 | 98.59 | 103.53 |
Net Income to Common | -111.22 | -122.45 | -192.47 | 73.14 | 98.59 | 103.53 |
Net Income Growth | - | - | - | -25.82% | -4.76% | -29.64% |
Shares Outstanding (Basic) | 143 | 142 | 143 | 143 | 133 | 107 |
Shares Outstanding (Diluted) | 143 | 142 | 143 | 143 | 133 | 107 |
Shares Change (YoY) | -0.19% | -0.13% | -0.58% | 7.63% | 24.73% | -0.04% |
EPS (Basic) | -0.78 | -0.86 | -1.35 | 0.51 | 0.74 | 0.97 |
EPS (Diluted) | -0.78 | -0.86 | -1.35 | 0.51 | 0.74 | 0.97 |
EPS Growth | - | - | - | -31.08% | -23.65% | -29.61% |
Free Cash Flow | -122.25 | -69.81 | -48.03 | -169.54 | -190.49 | 23.85 |
Free Cash Flow Per Share | -0.85 | -0.49 | -0.34 | -1.18 | -1.43 | 0.22 |
Dividend Per Share | - | - | - | 0.100 | 0.154 | - |
Dividend Growth | - | - | - | -34.98% | - | - |
Gross Margin | 8.27% | 7.95% | 4.88% | 18.71% | 22.23% | 24.33% |
Operating Margin | -5.10% | -5.65% | -13.02% | 4.49% | 7.83% | 9.85% |
Profit Margin | -5.58% | -6.08% | -11.45% | 3.78% | 6.07% | 6.60% |
Free Cash Flow Margin | -6.13% | -3.47% | -2.86% | -8.77% | -11.72% | 1.52% |
EBITDA | 81.54 | 61.7 | -54.02 | 239.01 | 241.32 | 259.73 |
EBITDA Margin | 4.09% | 3.06% | -3.21% | 12.36% | 14.85% | 16.56% |
D&A For EBITDA | 183.28 | 175.39 | 164.87 | 152.12 | 114.04 | 105.2 |
EBIT | -101.74 | -113.69 | -218.9 | 86.89 | 127.28 | 154.53 |
EBIT Margin | -5.10% | -5.65% | -13.02% | 4.49% | 7.83% | 9.85% |
Effective Tax Rate | - | - | - | - | 9.46% | 12.89% |
Revenue as Reported | 1,995 | 2,014 | 1,681 | 1,933 | 1,625 | 1,568 |
Advertising Expenses | - | 1.67 | 1.73 | 0.77 | 1.85 | 1.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.